This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL | MicrobiomeTrials
← Back to trials NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2023-05-17Est. Completion: 2033-10-31
Enrollment target: 100 participantsLocations St. Anna Kinderspital, Vienna, Austria Cliniques universitaires Saint-Luc, Brussels, Bruxelles-capitale, Région de, Belgium UZ Gent, Ghent, Oost-vlaanderen, Belgium UZ Leuven, Leuven, Vlaams-brabant, Belgium Detska nemocnice FN Brno, Brno, Brno-město, Czechia Fakultni Nemocnice Motol a Homolka, Prague, Czechia Rigshospitalet, Copenhagen, Capital Region, Denmark Helsinki university hospital, Helsinki, Finland Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, Alpes-maritimes, France CHU Strasbourg-Hautepierre, Service d'hematologie oncologie pediatrique, pediatrie 3, Strasbourg, Alsace, France Bordeaux University Hospital - Pellegrin, Bordeaux, Aquitaine, France CHU de Toulouse - Hôpital des Enfants - Hemato-Immuno-Oncologie, Toulouse, Haute-garonne, France Hôpital Arnaud de Villeneuve - CHU Montpellier, Montpellier, Hérault, France Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandœuvre-lès-Nancy, Meurthe-et-moselle, France Hôpital Jeanne de Flandre - CHRU, Lille, NORD, France Other microbiome trials you might be interested in B-All Acute Lymphoblastic Leukemia
Background:
Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…
Los Angeles, United States Est. completion Dec 31, 2026
Acute Lymphoblastic Leukemia
This is a prospective specimen collection study evaluating the feasibility of using the ChromoSeq® assay for upfront cla…
St Louis, United States Est. completion Jul 15, 2028
Assistance Publique - Hopitaux de Paris (AP-HP) - Hopital Robert Debre - Centre Hospitalo Universita, Paris, Paris, France
Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France
CHU de Nantes - Hôpital Mère - Enfants, Nantes, France
Hôpital Armand Trousseau, Paris, France
CHRU De Rennes - Hôpital Sud, Rennes, France
Universitaetsklinikum Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, Germany
Universitaetsklinikum Tuebingen, Tübingen, Baden-Wurttemberg, Germany
Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany
Universitaetsklinikum Wuerzburg, Würzburg, Bavaria, Germany
Universitätsklinikum Frankfurt Goethe-Universität, Frankfurt am Main, Hesse, Germany
Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany
Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, Germany
Universitätsklinikum Münster - Albert Schweitzer Campus, Münster, North Rhine-Westphalia, Germany
Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany
Charité Campus Virchow-Klinikum, Berlin, Germany
Universitaetsklinikum Duesseldorf, Düsseldorf, Germany
Universitätsklinikum Gießen, Giessen, Germany
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany
Medizinische Hochschule Hannover, Hanover, Germany
Universitätsklinikum Jena, Jena, Germany
Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, Hungary
Semmelweis Egyetem, Budapest, Hungary
Medanta - The Medicity, Gurugram, Haryana, India
Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Schneider Children's Medical Center, Petah Tikva, Central District, Israel
The Edmond and Lily Safra Children's Hospital; The Chaim Sheba Medical Center, Ramat Gan, Central District, Israel
Rambam Health Care Campus, Haifa, Northern District, Israel
Tel-Aviv Sourasky Medical Center Dana-Dwek Children's Hospital, Tel Aviv, TELL ABĪB, Israel
Azienda Ospedaliera di Rilievo Nazional Santobono Pausilipon, Naples, Campania, Italy
IRCCS Istituto Giannina Gaslini, Genoa, Liguria, Italy
Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardy, Italy
Ospedale Pediatrico Bambino Gesù IRCCS, Rome, ROMA, Italy
Policlinico "G. Rodolico", Catania, Sicily, Italy
Azienda Ospedale - Università Padova, Padova, Veneto, Italy
IRCCS - AOU di Bologna, Bologna, Italy
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Ospedale Regina Margherita, Torino, Italy
IRCCS Materno Infantile Burlo Garofolo, Trieste, Italy
Prinses Maxima Centrum voor Kinderoncologie, Utrecht, Netherlands
Oslo Universitetssykehus Rikshospitalet, Oslo, Norway
Radium Hospital, Oslo, Norway
Szpital Uniwersytecki nr 1 im. dr. A. Jurasza w Bydgoszczy, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Wroclaw, Lower Silesian Voivodeship, Poland
Narodny ustav detskych chorob, Bratislava, Bratislava Region, Slovakia
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [LA Coruña], Spain
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona], Spain
Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona [barcelona], Spain
Hospital Infantil Universitario Niño Jesús, Madrid, Madrid, Comunidad de, Spain
Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Hospital Universitario La Paz, Madrid, Spain
CHUS - Hospital Clinico Universitario, Santiago de Compostela, Spain
Hospital Universitario Virgen Del Rocio, Seville, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
Skånes Universitetssjukhus Lund, Lund, Skåne LÄN [se-12], Sweden
Sahlgrenska Universitetssjukhuset Östra, Gothenburg, Västra Götalands LÄN [se-14], Sweden
Astrid Lindgrens Barnsjukhus, Stockholm, Sweden
Inselspital Bern, Bern, Canton of Bern, Switzerland
CHUV (centre hospitalier universitaire vaudois), Lausanne, Canton of Vaud, Switzerland
Kinderspital Zürich, Zurich, Switzerland Phase 2
Recruiting
Acute Lymphoblastic Leukemia B-All
Background:
Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy invol…
Bethesda, United States Est. completion Jan 31, 2030